Inotiv
NOTV
#10058
Rank
โ‚น2.57 B
Marketcap
โ‚น74.82
Share price
2.76%
Change (1 day)
-77.46%
Change (1 year)

Revenue for Inotiv (NOTV)

Revenue in 2025 (TTM): โ‚น43.04 Billion

According to Inotiv's latest financial reports the company's current revenue (TTM ) is โ‚น45.54 Billion. In 2024 the company made a revenue of โ‚น40.75 Billion a decrease over the revenue in the year 2023 that were of โ‚น48.71 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inotiv from 1998 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น43.04 B5.61%
2024 โ‚น40.75 B-16.33%
2023 โ‚น48.71 B0.43%
2022 โ‚น48.50 B317.95%
2021 โ‚น11.60 B142.52%
2020 โ‚น4.78 B40.08%
2019 โ‚น3.41 B65.1%
2018 โ‚น2.06 B38.23%
2017 โ‚น1.49 B1.42%
2016 โ‚น1.47 B2.13%
2015 โ‚น1.44 B-5.8%
2014 โ‚น1.53 B10.46%
2013 โ‚น1.38 B-4.25%
2012 โ‚น1.45 B-15.8%
2011 โ‚น1.72 B26.09%
2010 โ‚น1.36 B-2.11%
2009 โ‚น1.39 B-27.28%
2008 โ‚น1.91 B11.01%
2007 โ‚น1.72 B-11.44%
2006 โ‚น1.95 B1.99%
2005 โ‚น1.91 B16.13%
2004 โ‚น1.64 B14.44%
2003 โ‚น1.44 B9.39%
2002 โ‚น1.31 B5.5%
2001 โ‚น1.24 B32.38%
2000 โ‚น0.94 B9.94%
1999 โ‚น0.85 B9.04%
1998 โ‚น0.78 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
โ‚น12.53 B-72.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas